Application of Human Leukocyte Antigen-G Expression in the Diagnosis of Human Cancer

Human Immunology

Volumn 68, Issue 4, 2007, Pages 272-276

  Shih, Ie Ming ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

detection; diagnosis; human cancer; prognosis

Indexed keywords

BIOLOGICAL MARKER; HLA G ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; PROGNOSIS; TROPHOBLASTIC DISEASE;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33947684890     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.01.010     Document Type: Article

References (21)

1. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220
2. Rouas-Freiss N., Moreau P., Ferrone S., and Carosella E.D. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?. Cancer Res 65 (2005) 10139
3. Kleinberg L., Florenes V.A., Skrede M., Dong H.P., Nielsen S., McMaster M.T., Nesland J.M., Shih I.-M., and Davidson B. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch 449 (2006) 31
4. Hansel D.E., Rahman A., Wilentz R.E., Shih I.-M., McMaster M.T., Yeo C.J., and Maitra A. HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer 35 (2005) 15
5. Singer G., Kurman R.J., McMaster M., and Shih I.-M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26 (2002) 914
6. Singer G., Rebmann V., Chen Y.C., Liu H.T., Ali S.Z., Reinsberg J., McMaster M.T., Pfeiffer K., Chan D.W., Wardelmann E., Grosse-Wilde H., Cheng C.C., Kurman R.J., and Shih I.M. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 9 (2003) 4460
7. Bukur J., Rebmann V., Grosse-Wilde H., Luboldt H., Ruebben H., Drexler I., Sutter G., Huber C., and Seliger B. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 63 (2003) 4107
8. Urosevic M., Kurrer M.O., Kamarashev J., Mueller B., Weder W., Burg G., Stahel R.A., Dummer R., and Trojan A. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 159 (2001) 817
9. Rebmann V., Pfeiffer K., Passler M., Ferrone S., Maier S., Weiss E., and Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53 (1999) 14
10. Rebmann V., Regel J., Stolke D., and Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 13 (2003) 371
11. Rebmann V., van der Ven K., Passler M., Pfeiffer K., Krebs D., and Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57 (2001) 15
12. Leleu X., Le Friec G., Facon T., Amiot L., Fauchet R., Hennache B., Coiteux V., Yakoub-Agha I., Dubucquoi S., Avet-Loiseau H., Mathiot C., Bataille R., and Mary J.Y. Total soluble HLA class I and soluble HLA-G in multiple myeloma and monoclonal gammopathy of undetermined significance. Clin Cancer Res 11 (2005) 7297
13. Gros F., Sebti Y., de Guibert S., Branger B., Bernard M., Fauchet R., and Amiot L. Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages. Neoplasia 8 (2006) 223
14. Sebti Y., Le Friec G., Pangault C., Gros F., Drenou B., Guilloux V., Bernard M., Lamy T., Fauchet R., and Amiot L. Soluble HLA-G molecules are increased in lymphoproliferative disorders. Hum Immunol 64 (2003) 1093
15. Motherby H., Nadjari B., Friegel P., Kohaus J., Ramp U., and Bocking A. Diagnostic accuracy of effusion cytology. Diagn Cytopathol 20 (1999) 350
16. Rebmann V., Busemann A., Lindemann M., and Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 64 (2003) 1017
17. Barrier B.F., Kendall B.S., Sharpe-Timms K.L., and Kost E.R. Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol 103 (2006) 25
18. Singer G., Rebmann V., Chen Y.-C., Liu H.-T., Ali S.Z., Reinsberg J., McMaster M., Pfeiffer K., Chan D.W., Wardelmann E., Grosse-Wilde H., Kurman R.J., and Shih I.-M. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 9 (2003) 4460
19. Davidson B., Elstrand M.B., McMaster M.T., Berner A., Kurman R.J., Risberg B., Trope C.G., and Shih I.-M. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecol Oncol 96 (2005) 42
20. Ishigami S., Natsugoe S., Miyazono F., Nakajo A., Tokuda K., Matsumoto M., Okumura H., Douchi T., Hokita S., and Aikou T. HLA-G expression in gastric cancer. Anticancer Res 26 (2006) 2467
21. Nuckel H., Rebmann V., Durig J., Duhrsen U., and Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 105 (2005) 1694